It’s a bright Friday afternoon, and the sunlight pours into the glass-faced foyer of the Mitchell Cancer Institute, in Mobile. Michael Chambers, president and CEO of Swift Biotechnology, clutches an oversized coffee mug and explains he’s been on the road for the past several days attending speaking engagements throughout the region. Where exactly? “Let me…
